Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?
Open Access
- 15 February 2000
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 95 (4) , 1113-1116
- https://doi.org/10.1182/blood.v95.4.1113.004k54_1113_1116
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitorJournal of Clinical Investigation, 1999
- Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.Journal of Clinical Investigation, 1998
- Tissue Factor Cytoplasmic Domain Peptide Is Multiply Phosphorylated in VitroBiochemistry, 1997
- Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo.Journal of Clinical Investigation, 1997
- Effector Cell Protease Receptor-1 Is a Vascular Receptor for Coagulation Factor XaPublished by Elsevier ,1996
- In vivo immunosuppression by targeting a novel protease receptorNature, 1996
- Protease-Dependent T Cell Activation: Ligation of Effector Cell Protease Receptor-1 (EPR-1) Stimulates Lymphocyte ProliferationCellular Immunology, 1994
- Antithrombin III: physiology, deficiency, and replacement therapyTransfusion, 1992
- Regulation of coagulation by a multivalent Kunitz-type inhibitorBiochemistry, 1990
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.Journal of Clinical Investigation, 1987